Endoceutics Secures $85M Credit Facility from CRG

Endoceutics, Inc., a Quebec City-Canada based biopharma company, entered into a long-term $85m senior credit facility with CRG LP, a healthcare-focused investment firm.

Led by Dr. Fernand Labrie, Founder and Chairman, Endoceutics is a private pharmaceutical company operating in the field of women’s health and hormone-sensitive cancer prevention and treatment.
Following approval by the FDA of Intrarosa™ in November 2016, for the treatment of dyspareunia, a symptom of vulvovaginal atrophy due to menopause, Endoceutics focuses on developing non estrogen-based therapies for sexual dysfunction and the other symptoms of menopause, including hot flushes, osteoporosis, muscle loss and type 2 diabetes.

The company intends to use the funds for the commercial launch of its FDA-approved product, Intrarosa™, and fund additional research and development in its women’s health and oncology focused pipeline.



Join the discussion